Yang JM - Search Results

1

The individualization of cancer therapy: the unexpected role of p53.

Hait WN, Yang JM. Hait WN, et al. Among authors: yang jm. Trans Am Clin Climatol Assoc. 2006;117:85-101; discussion 101. Trans Am Clin Climatol Assoc. 2006. PMID: 18528466 Free PMC article. Review.

2

Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells.

Sullivan GF, Yang JM, Vassil A, Yang J, Bash-Babula J, Hait WN. Sullivan GF, et al. Among authors: yang jm, yang j. J Clin Invest. 2000 May;105(9):1261-7. doi: 10.1172/JCI9290. J Clin Invest. 2000. PMID: 10792001 Free PMC article.

3

Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.

Yang J, Yang JM, Iannone M, Shih WJ, Lin Y, Hait WN. Yang J, et al. Among authors: yang jm. Cancer Res. 2001 May 15;61(10):4010-6. Cancer Res. 2001. PMID: 11358819

4

Involvement of phosphatidylinositol-3-kinase in membrane ruffling induced by P-glycoprotein substrates in multidrug-resistant carcinoma cells.

Yang JM, Vassil A, Hait WN. Yang JM, et al. Biochem Pharmacol. 2002 Mar 1;63(5):959-66. doi: 10.1016/s0006-2952(02)00838-9. Biochem Pharmacol. 2002. PMID: 11911848

5

A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.

Bash-Babula J, Toppmeyer D, Labassi M, Reidy J, Orlick M, Senzon R, Alli E, Kearney T, August D, Shih W, Yang JM, Hait WN. Bash-Babula J, et al. Among authors: yang jm. Clin Cancer Res. 2002 May;8(5):1057-64. Clin Cancer Res. 2002. PMID: 12006519 Clinical Trial.

6

Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus.

Arora S, Yang JM, Craft J, Hait W. Arora S, et al. Among authors: yang jm. Biochem Biophys Res Commun. 2002 May 10;293(3):1073-6. doi: 10.1016/S0006-291X(02)00324-8. Biochem Biophys Res Commun. 2002. PMID: 12051769

7

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

Alli E, Bash-Babula J, Yang JM, Hait WN. Alli E, et al. Among authors: yang jm. Cancer Res. 2002 Dec 1;62(23):6864-9. Cancer Res. 2002. PMID: 12460900

8

Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells.

Wu H, Hait WN, Yang JM. Wu H, et al. Among authors: yang jm. Cancer Res. 2003 Apr 1;63(7):1515-9. Cancer Res. 2003. PMID: 12670898

9

Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.

Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN. Yang JM, et al. Mol Cancer Res. 2003 Apr;1(6):420-7. Mol Cancer Res. 2003. PMID: 12692261

10

Effect of the multidrug resistance protein on the transport of the antiandrogen flutamide.

Grzywacz MJ, Yang JM, Hait WN. Grzywacz MJ, et al. Among authors: yang jm. Cancer Res. 2003 May 15;63(10):2492-8. Cancer Res. 2003. PMID: 12750271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,787 results

Search Page

Filters